[{"id":"88a665b1-a5c9-4bf5-8010-cb1f2a61c47b","acronym":"","url":"https://clinicaltrials.gov/study/NCT04049903","created_at":"2021-01-18T19:51:39.503Z","updated_at":"2024-07-02T16:35:58.685Z","phase":"Phase 1","brief_title":"Study to Investigate the Safety, Blood Levels and Activity of MP0310 in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT04049903","lead_sponsor":"Molecular Partners AG","biomarkers":" MSI","pipe":" | ","alterations":" MSI-H/dMMR","tags":["MSI"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSI-H/dMMR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MP0310"],"overall_status":"Completed","enrollment":" Enrollment 38","initiation":"Initiation: 09/02/2019","start_date":" 09/02/2019","primary_txt":" Primary completion: 06/27/2022","primary_completion_date":" 06/27/2022","study_txt":" Completion: 12/21/2022","study_completion_date":" 12/21/2022","last_update_posted":"2022-12-22"}]